Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ellen P Casavant

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|November 12, 2022
Using SILAC to Develop Quantitative Data-Independent Acquisition (DIA) Proteomic MethodsEllen P Casavant, Jason Liang, Sumedh Sankhe, et al.
ACS Chemical Biology|June 26, 2014
Structure, biochemistry, and inhibition of essential 4'-phosphopantetheinyl transferases from two species of MycobacteriaChristopher R Vickery, Nicolas M Kosa, Ellen P Casavant, et al.
Scientific Reports|August 30, 2019
Latent-period stool proteomic assay of multiple sclerosis model indicates protective capacity of host-expressed protease inhibitorsCarlos G Gonzalez, Stephanie K Tankou, Laura M Cox, et al.
Proteomics. Clinical Applications|March 29, 2024
Comprehensive profiling of the human fecal proteome from IBD patients with DIA-MS enables evaluation of disease-relevant proteinsBrandon J Harder, Annemarie N Lekkerkerker, Ellen P Casavant, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Methods in Molecular Biology (Clifton, N.J.)|November 12, 2022
Using SILAC to Develop Quantitative Data-Independent Acquisition (DIA) Proteomic MethodsEllen P Casavant, Jason Liang, Sumedh Sankhe, et al.
ACS Chemical Biology|June 26, 2014
Structure, biochemistry, and inhibition of essential 4'-phosphopantetheinyl transferases from two species of MycobacteriaChristopher R Vickery, Nicolas M Kosa, Ellen P Casavant, et al.
Scientific Reports|August 30, 2019
Latent-period stool proteomic assay of multiple sclerosis model indicates protective capacity of host-expressed protease inhibitorsCarlos G Gonzalez, Stephanie K Tankou, Laura M Cox, et al.
Proteomics. Clinical Applications|March 29, 2024
Comprehensive profiling of the human fecal proteome from IBD patients with DIA-MS enables evaluation of disease-relevant proteinsBrandon J Harder, Annemarie N Lekkerkerker, Ellen P Casavant, et al.
Pageof 1